Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-initiated Trial Evaluating the Efficacy and Safety of Recombinant Adeno-associated Virus Administration in Patients With Menkes Syndrome

NCT05507996 is registered in ClinicalTrials.gov with Kunming Hope of Health Hospital as lead sponsor.

NCT NCT05507996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05507996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-initiated Trial Evaluating the Efficacy and Safety of Recombinant Adeno-associated Virus Administration in Patients With Menkes Syndrome
Lead sponsor
Kunming Hope of Health Hospital
Phase
Phase 1
Overall status
Terminated
Start date
August 18, 2022
Completion date
November 23, 2022
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menkes syndrome